David M Markovitz
Professor of Internal Medicine
[email protected]

Available to mentor
David M Markovitz
Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Center for Cell Plasticity and Organ Design
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Non-targeted isomer-sensitive N-glycome analysis reveals new layers of organ-specific diversity in mice.
      Stadlmann J, Helm J, Mereiter S, Oliveira T, Gattinger A, Markovitz D, Penninger J, Altmann F. Res Sq, 2024 Apr 9; DOI:10.21203/rs.3.rs-4130712/v1
      PMID: 38659835
    • Preprint
      A molecularly engineered lectin destroys EGFR and inhibits the growth of non-small cell lung cancer.
      Chan SM, Raglow Z, Pal A, Gitlin SD, Legendre M, Thomas D, Mehta RK, Tan M, Nyati MK, Rehemtulla A, Markovitz DM. 2024 Mar 20; DOI:10.1101/2024.03.18.585535
      PMID: 38562773
    • Journal Article
      Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma.
      McKenna MK, Ozcan A, Brenner D, Watanabe N, Legendre M, Thomas DG, Ashwood C, Cummings RD, Bonifant C, Markovitz DM, Brenner MK. J Immunother Cancer, 2023 Jan; 11 (1): DOI:10.1136/jitc-2022-005891
      PMID: 36653070
    • Journal Article
      Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis.
      Paul S, Kaplan MH, Khanna D, McCourt PM, Saha AK, Tsou P-S, Anand M, Radecki A, Mourad M, Sawalha AH, Markovitz DM, Contreras-Galindo R. Nat Commun, 2022 Nov 18; 13 (1): 7074 DOI:10.1038/s41467-022-34775-8
      PMID: 36400785
    • Journal Article
      H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice.
      Lloyd MG, Liu D, Legendre M, Markovitz DM, Moffat JF. Sci Rep, 2022 Jan 31; 12 (1): 1641 DOI:10.1038/s41598-022-05580-6
      PMID: 35102178
    • Journal Article
      Extracellular DEK Activates NRF2 Antioxidant Targets and Drives Expansion of Functional and ROS-Low Human Hematopoietic Stem Cells
      Ropa J, Gutch S, Beasley L, Neuville PA, Cooper S, Cao D, Hof WV, Legendre M, Kaplan M, Markovitz DM, Capitano ML. Blood, 2022 Nov 15; 140 (Supplement 1): 8576 - 8577. DOI:10.1182/blood-2022-170089
    • Journal Article
      A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
      Chan JF-W, Oh YJ, Yuan S, Chu H, Yeung M-L, Canena D, Chan CC-S, Poon VK-M, Chan CC-Y, Zhang AJ, Cai J-P, Ye Z-W, Wen L, Yuen TT-T, Chik KK-H, Shuai H, Wang Y, Hou Y, Luo C, Chan W-M, Qin Z, Sit K-Y, Au W-K, Legendre M, Zhu R, Hain L, Seferovic H, Tampé R, To KK-W, Chan K-H, Thomas DG, Klausberger M, Xu C, Moon JJ, Stadlmann J, Penninger JM, Oostenbrink C, Hinterdorfer P, Yuen K-Y, Markovitz DM. Cell Rep Med, 2022 Oct 18; 3 (10): 100774 DOI:10.1016/j.xcrm.2022.100774
      PMID: 36195094
    • Journal Article
      Targeting glycans for CAR therapy: The advent of sweet CARs.
      Raglow Z, McKenna MK, Bonifant CL, Wang W, Pasca di Magliano M, Stadlmann J, Penninger JM, Cummings RD, Brenner MK, Markovitz DM. Mol Ther, 2022 Sep 7; 30 (9): 2881 - 2890. DOI:10.1016/j.ymthe.2022.07.006
      PMID: 35821636